Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
A form of von Willebrand's disease has been described with enhanced ristocetin-induced platelet aggregation and anodal migration of the factor VIII/von Willebrand factor protein (type IIb). We studied two families with this form of von Willebrand's disease and macrothrombocytopenia. We have found that these platelets bind more of the normal and intermediate-sized multimers of the factor VIII/von Willebrand factor than normal platelets. Analysis of the binding data show an increased affinity of these vWd platelets for the factor VIII/von Willebrand factor. These findings are consistent with an increased number of platelet receptors, which, either by their native topography or migration on the platelet surface, bind factor VIII/von Willebrand factor protein with greater affinity than normal platelets, platelets of other vWd patients, and large platelets of other etiologies.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000915:Antibody Affinity; D001779:Blood Coagulation Factors / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology*; D002648:Child; D005169:Factor VIII / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D011971:Receptors, Immunologic; D012310:Ristocetin / Q000494:pharmacology; D014842:von Willebrand Diseases / Q000097:blood / Q000276:immunology*; D014841:von Willebrand Factor / Q000276:immunology*
D001779:Blood Coagulation Factors; D011971:Receptors, Immunologic; D014841:von Willebrand Factor; D012310:Ristocetin; D005169:Factor VIII